You Are On:
EQUITY
Equity Analysis
  Price
    Gainers & Losers
    Out & Under Performers
    Only Buyers & Sellers
     Advances & Declines
     New Highs & Lows
     Weightage
     5 Day's Up & Down
  Volume
  Analysis
News Analysis
Corporate Info
Corporate Action
Other Market
Financial Ratios    
Bal Pharma Ltd.
 
BSE Code 524824
ISIN Demat INE083D01012
Book Value 62.40
NSE Code BALPHARMA
Dividend Yield(%) 0.97
Market Cap(Million) 1626.84
P/E(X) 26.35
EPS(Rs.) 3.91
Face Value(Rs.) 10  
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)3.90  5.79  6.14  -6.28  4.77  
   CEPS(Rs)8.67  10.67  11.03  -1.32  9.08  
   DPS(Rs)1.00  1.00  1.00  0.00  1.00  
   Book NAV/Share(Rs)60.32  57.66  52.88  46.53  54.23  
   Tax Rate(%)28.34  28.84  7.14  1.92  -53.27  
Margin Ratios          
   Core EBITDA Margin(%)8.63  8.36  10.63  4.11  9.18  
   EBIT Margin(%)6.87  8.08  8.80  2.12  7.67  
   Pre Tax Margin(%)2.82  4.30  3.93  -5.32  1.98  
   PAT Margin (%)2.02  3.06  3.65  -5.22  3.03  
   Cash Profit Margin (%)4.49  5.64  6.56  -1.10  5.77  
Performance Ratios          
   ROA(%)1.92  3.11  3.63  -3.59  2.66  
   ROE(%)6.80  10.47  12.61  -12.47  9.07  
   ROCE(%)10.25  12.28  12.57  2.09  9.95  
   Asset Turnover(x)0.95  1.02  1.00  0.69  0.88  
   Sales/Fixed Asset(x)3.04  3.15  2.96  2.15  3.02  
   Working Capital/Sales(x)5.24  5.38  5.38  5.93  4.91  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.33  0.32  0.34  0.46  0.33  
   Receivable days104.01  95.91  88.65  125.48  106.15  
   Inventory Days103.36  87.29  93.46  146.56  111.00  
   Payable days190.52  144.48  114.32  209.22  171.49  
Valuation Parameters          
   PER(x)17.14  18.63  8.76  0.00  14.78  
   PCE(x)7.72  10.11  4.87  -24.60  7.76  
   Price/Book(x)1.11  1.87  1.02  0.70  1.30  
   Yield(%)1.49  0.93  1.86  0.00  1.42  
   EV/Net Sales(x)0.74  0.90  0.72  0.84  0.90  
   EV/Core EBITDA(x)7.87  8.46  6.17  13.40  8.62  
   EV/EBIT(x)10.70  11.16  8.21  39.42  11.70  
   EV/CE(x)0.64  0.87  0.69  0.60  0.78  
   M Cap / Sales0.35  0.57  0.32  0.27  0.45  
Growth Ratio          
   Net Sales Growth(%)8.11  12.46  46.07  -23.49  7.43  
   Core EBITDA Growth(%)-5.28  2.39  174.27  -54.18  -5.45  
   EBIT Growth(%)-8.05  3.27  506.36  -78.86  -4.06  
   PAT Growth(%)-28.59  -5.69  202.19  -231.69  13.84  
   EPS Growth(%)-32.54  -5.69  197.71  -231.69  13.84  
Financial Stability Ratios          
   Total Debt/Equity(x)1.32  1.15  1.33  1.51  1.36  
   Current Ratio(x)1.27  1.31  1.32  1.21  1.32  
   Quick Ratio(x)0.81  0.87  0.91  0.73  0.85  
   Interest Cover(x)1.70  2.14  1.81  0.29  1.35  
   Total Debt/Mcap(x)1.19  0.61  1.31  2.16  1.05